1. Home
  2. FOXX vs HUMAW Comparison

FOXX vs HUMAW Comparison

Compare FOXX & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXX
  • HUMAW
  • Stock Information
  • Founded
  • FOXX 2017
  • HUMAW N/A
  • Country
  • FOXX United States
  • HUMAW United States
  • Employees
  • FOXX N/A
  • HUMAW 185
  • Industry
  • FOXX
  • HUMAW Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOXX
  • HUMAW Health Care
  • Exchange
  • FOXX Nasdaq
  • HUMAW Nasdaq
  • Market Cap
  • FOXX N/A
  • HUMAW N/A
  • IPO Year
  • FOXX N/A
  • HUMAW 2020
  • Fundamental
  • Price
  • FOXX $6.00
  • HUMAW $1.28
  • Analyst Decision
  • FOXX
  • HUMAW
  • Analyst Count
  • FOXX 0
  • HUMAW 0
  • Target Price
  • FOXX N/A
  • HUMAW N/A
  • AVG Volume (30 Days)
  • FOXX 290.0K
  • HUMAW N/A
  • Earning Date
  • FOXX 02-15-2025
  • HUMAW N/A
  • Dividend Yield
  • FOXX N/A
  • HUMAW N/A
  • EPS Growth
  • FOXX N/A
  • HUMAW N/A
  • EPS
  • FOXX N/A
  • HUMAW N/A
  • Revenue
  • FOXX $26,340,611.00
  • HUMAW N/A
  • Revenue This Year
  • FOXX N/A
  • HUMAW N/A
  • Revenue Next Year
  • FOXX N/A
  • HUMAW N/A
  • P/E Ratio
  • FOXX N/A
  • HUMAW N/A
  • Revenue Growth
  • FOXX N/A
  • HUMAW N/A
  • 52 Week Low
  • FOXX $2.89
  • HUMAW N/A
  • 52 Week High
  • FOXX $14.99
  • HUMAW N/A
  • Technical
  • Relative Strength Index (RSI)
  • FOXX N/A
  • HUMAW N/A
  • Support Level
  • FOXX N/A
  • HUMAW N/A
  • Resistance Level
  • FOXX N/A
  • HUMAW N/A
  • Average True Range (ATR)
  • FOXX 0.00
  • HUMAW 0.00
  • MACD
  • FOXX 0.00
  • HUMAW 0.00
  • Stochastic Oscillator
  • FOXX 0.00
  • HUMAW 0.00

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Share on Social Networks: